Early infectious complications among patients treated with induction compared to hypomethylating therapy for acute myeloid leukemia.
作者信息
Jalbut Marla M, Brunner Andrew M, Amrein Philip C, Ballen Karen K, Hobbs Gabriela S, Perry Ashley M, Joseph Christelle P, Fathi Amir T
机构信息
a Division of Hematology/Oncology , Massachusetts General Hospital, Harvard Medical School , Boston , MA , USA.
b Tufts University School of Medicine , Boston , MA , USA.
出版信息
Leuk Lymphoma. 2018 Apr;59(4):988-991. doi: 10.1080/10428194.2017.1361028. Epub 2017 Aug 9.
Abstract
摘要
相似文献
1
Early infectious complications among patients treated with induction compared to hypomethylating therapy for acute myeloid leukemia.与急性髓系白血病的低甲基化治疗相比，接受诱导治疗的患者早期感染并发症情况。
Leuk Lymphoma. 2018 Apr;59(4):988-991. doi: 10.1080/10428194.2017.1361028. Epub 2017 Aug 9.
2
Hypomethylating agents super-responders: challenging the dogma of long-term remission for acute myeloid leukemia.低甲基化药物超反应者：挑战急性髓系白血病长期缓解的教条。
Ann Hematol. 2020 Jun;99(6):1411-1413. doi: 10.1007/s00277-020-04054-x. Epub 2020 May 6.
3
Conventional chemotherapy or hypomethylating agents for older patients with acute myeloid leukaemia?对于老年急性髓系白血病患者，采用常规化疗还是低甲基化药物治疗？
Hematol Oncol. 2014 Mar;32(1):1-9. doi: 10.1002/hon.2046. Epub 2013 Mar 20.
4
Use of decitabine for patients with refractory or relapsed acute myeloid leukemia: a systematic review and meta-analysis.地西他滨用于难治性或复发性急性髓系白血病患者：一项系统评价和荟萃分析。
Hematology. 2019 Dec;24(1):507-515. doi: 10.1080/16078454.2019.1632407.
5
Effect of granulocyte colony-stimulating factor on outcomes in patients with non-M3 acute myelogenous leukemia treated with anthracycline-based induction (7+3 regimen) chemotherapies.粒细胞集落刺激因子对接受蒽环类诱导（7+3方案）化疗的非M3型急性髓系白血病患者结局的影响。
Leuk Res. 2017 Jun;57:1-8. doi: 10.1016/j.leukres.2017.02.003. Epub 2017 Feb 8.
6
Rebound thrombocytosis is associated with response in AML patients treated with venetoclax and hypomethylating agents.反应性血小板增多症与接受维奈克拉和低甲基化药物治疗的急性髓系白血病（AML）患者的反应相关。
Am J Hematol. 2021 May 1;96(5):E140-E143. doi: 10.1002/ajh.26117. Epub 2021 Feb 18.
7
Feasibility, efficacy, and adverse effects of outpatient antibacterial prophylaxis in children with acute myeloid leukemia.急性髓系白血病患儿门诊抗菌药物预防的可行性、疗效及不良反应
Cancer. 2014 Jul 1;120(13):1985-92. doi: 10.1002/cncr.28688. Epub 2014 Mar 26.
8
Decitabine Versus Intensive Chemotherapy for Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia.地西他滨与强化化疗治疗新诊断的老年急性髓系白血病患者的比较
Clin Lymphoma Myeloma Leuk. 2019 May;19(5):290-299.e3. doi: 10.1016/j.clml.2019.02.002. Epub 2019 Feb 20.
9
Clinical outcome of treatment with a combined regimen of decitabine and aclacinomycin/cytarabine for patients with refractory acute myeloid leukemia.地西他滨联合阿克拉霉素/阿糖胞苷治疗难治性急性髓系白血病的临床疗效。
Ann Hematol. 2012 Dec;91(12):1879-86. doi: 10.1007/s00277-012-1550-y. Epub 2012 Aug 16.
10
Outcomes of therapy with venetoclax combined with a hypomethylating agent in favorable-risk acute myeloid leukemia.维奈托克联合低甲基化药物治疗低危急性髓系白血病的疗效
Am J Hematol. 2021 Mar 1;96(3):E59-E63. doi: 10.1002/ajh.26057. Epub 2020 Dec 8.
引用本文的文献
1
Impact of treatment intensity on infectious complications in patients with acute myeloid leukemia.治疗强度对急性髓系白血病患者感染并发症的影响。
J Cancer Res Clin Oncol. 2023 Apr;149(4):1569-1583. doi: 10.1007/s00432-022-03995-2. Epub 2022 May 18.
本文引用的文献
1
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society.成人医院获得性肺炎和呼吸机相关性肺炎的管理：美国感染病学会和美国胸科学会2016年临床实践指南
Clin Infect Dis. 2016 Sep 1;63(5):e61-e111. doi: 10.1093/cid/ciw353. Epub 2016 Jul 14.
2
International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts.阿扎胞苷对比传统治疗方案用于新诊断的原始细胞比例>30%的老年急性髓系白血病患者的国际3期研究。
Blood. 2015 Jul 16;126(3):291-9. doi: 10.1182/blood-2015-01-621664. Epub 2015 May 18.
3
Use of ED and hospital services for patients with acute leukemia after induction therapy: one year follow-up.诱导治疗后急性白血病患者急诊及住院服务的使用情况：一年随访
Leuk Res. 2015 Apr;39(4):406-10. doi: 10.1016/j.leukres.2015.01.006. Epub 2015 Feb 11.
4
Prediction of adverse events during intensive induction chemotherapy for acute myeloid leukemia or high-grade myelodysplastic syndromes.预测急性髓细胞白血病或高级别骨髓增生异常综合征强化诱导化疗期间的不良事件。
Am J Hematol. 2014 Apr;89(4):423-8. doi: 10.1002/ajh.23661. Epub 2014 Feb 24.
5
Epidemiology of bloodstream infections in patients with acute myeloid leukemia undergoing levofloxacin prophylaxis.接受左氧氟沙星预防的急性髓系白血病患者血流感染的流行病学。
BMC Infect Dis. 2013 Dec 1;13:563. doi: 10.1186/1471-2334-13-563.
6
Infectious complications in adult acute myeloid leukemia: analysis of the Acute Leukemia French Association-9802 prospective multicenter clinical trial.成人急性髓系白血病的感染并发症：急性白血病法国协会 9802 前瞻性多中心临床试验分析。
Leuk Lymphoma. 2012 Jun;53(6):1068-76. doi: 10.3109/10428194.2011.636812. Epub 2012 Jan 31.
7
Azacitidine in patients with acute myeloid leukemia medically unfit for or resistant to chemotherapy: a multicenter phase I/II study.不适合或对化疗耐药的急性髓系白血病患者用阿扎胞苷：一项多中心 I/II 期研究。
Leuk Lymphoma. 2012 Jan;53(1):110-7. doi: 10.3109/10428194.2011.606382. Epub 2011 Aug 24.
8
Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials.在英国医学研究理事会试验中治疗的 5876 例年轻成年患者中，对罕见重现染色体异常进行细胞遗传学分类的细化：确定其预后意义。
Blood. 2010 Jul 22;116(3):354-65. doi: 10.1182/blood-2009-11-254441. Epub 2010 Apr 12.
9
Multicenter, phase II study of decitabine for the first-line treatment of older patients with acute myeloid leukemia.多中心、Ⅱ期临床试验：地西他滨一线治疗老年急性髓系白血病患者。
J Clin Oncol. 2010 Feb 1;28(4):556-61. doi: 10.1200/JCO.2009.23.9178. Epub 2009 Dec 21.
10
Infections in acute myeloid leukemia: an analysis of 382 febrile episodes.急性髓细胞白血病的感染：382 例发热病例分析。
Med Oncol. 2010 Dec;27(4):1037-45. doi: 10.1007/s12032-009-9330-9. Epub 2009 Oct 15.
Zotero 插件